1. Home
  2. RYTM vs EQX Comparison

RYTM vs EQX Comparison

Compare RYTM & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • EQX
  • Stock Information
  • Founded
  • RYTM 2008
  • EQX 2007
  • Country
  • RYTM United States
  • EQX Canada
  • Employees
  • RYTM N/A
  • EQX N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • EQX Precious Metals
  • Sector
  • RYTM Health Care
  • EQX Basic Materials
  • Exchange
  • RYTM Nasdaq
  • EQX Nasdaq
  • Market Cap
  • RYTM 5.9B
  • EQX 4.9B
  • IPO Year
  • RYTM 2017
  • EQX N/A
  • Fundamental
  • Price
  • RYTM $97.61
  • EQX $7.98
  • Analyst Decision
  • RYTM Strong Buy
  • EQX
  • Analyst Count
  • RYTM 13
  • EQX 0
  • Target Price
  • RYTM $101.92
  • EQX N/A
  • AVG Volume (30 Days)
  • RYTM 578.8K
  • EQX 13.6M
  • Earning Date
  • RYTM 08-05-2025
  • EQX 08-13-2025
  • Dividend Yield
  • RYTM N/A
  • EQX N/A
  • EPS Growth
  • RYTM N/A
  • EQX N/A
  • EPS
  • RYTM N/A
  • EQX N/A
  • Revenue
  • RYTM $156,287,000.00
  • EQX $1,905,732,000.00
  • Revenue This Year
  • RYTM $37.86
  • EQX $59.63
  • Revenue Next Year
  • RYTM $72.72
  • EQX $44.19
  • P/E Ratio
  • RYTM N/A
  • EQX N/A
  • Revenue Growth
  • RYTM 53.55
  • EQX 74.31
  • 52 Week Low
  • RYTM $43.57
  • EQX $4.95
  • 52 Week High
  • RYTM $99.04
  • EQX $8.15
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 73.48
  • EQX 81.11
  • Support Level
  • RYTM $95.30
  • EQX $6.29
  • Resistance Level
  • RYTM $99.04
  • EQX $6.75
  • Average True Range (ATR)
  • RYTM 3.21
  • EQX 0.29
  • MACD
  • RYTM 0.20
  • EQX 0.16
  • Stochastic Oscillator
  • RYTM 90.50
  • EQX 91.40

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About EQX Equinox Gold Corp.

Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.

Share on Social Networks: